Wilmar International Limited (WLMIY)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,299	14,180	16,885	19,414	19,331	22,221
Market Cap Growth	-16.02%	-16.02%	-13.03%	0.43%	-13.00%	14.40%
Enterprise Value	37,829	33,221	41,597	47,721	43,050	45,488
Last Close Price	22.85	21.96	24.29	26.78	26.80	29.46
PE Ratio	12.22	12.12	11.07	8.08	10.23	14.48
PS Ratio	0.21	0.21	0.25	0.26	0.29	0.44
PB Ratio	0.64	0.63	0.74	0.86	0.86	1.04
P/TBV Ratio	0.97	0.96	1.13	1.33	1.33	1.65
P/FCF Ratio	-	-	10.08	-	-	-
P/OCF Ratio	10.42	10.34	4.35	9.48	-	40.20
EV/Sales Ratio	0.53	0.49	0.62	0.65	0.65	0.90
EV/EBITDA Ratio	9.54	9.77	12.71	11.31	11.38	14.51
EV/EBIT Ratio	14.57	14.90	19.09	14.96	15.45	20.50
EV/FCF Ratio	-189.15	-	24.84	-	-	-
Debt / Equity Ratio	1.28	1.28	1.36	1.36	1.30	1.10
Debt / EBITDA Ratio	8.13	8.13	9.15	7.09	7.55	7.25
Debt / FCF Ratio	-	-	18.51	-	-	-
Asset Turnover	1.11	1.11	1.10	1.23	1.20	1.03
Inventory Turnover	5.01	5.01	4.95	5.36	5.54	5.16
Quick Ratio	0.59	0.59	0.59	0.52	0.55	0.61
Current Ratio	1.12	1.12	1.16	1.09	1.12	1.22
Return on Equity (ROE)	5.44%	5.44%	7.31%	11.37%	9.40%	8.61%
Return on Assets (ROA)	2.30%	2.30%	2.23%	3.35%	3.17%	2.83%
Return on Capital (ROIC)	2.66%	2.66%	2.54%	3.79%	3.60%	3.20%
Return on Capital Employed (ROCE)	7.40%	7.40%	6.80%	10.50%	9.20%	7.90%
Earnings Yield	8.18%	8.25%	9.03%	12.38%	9.78%	6.90%
FCF Yield	-1.40%	-1.41%	9.92%	-2.24%	-13.30%	-6.40%
Dividend Yield	4.82%	0.53%	0.53%	0.47%	0.43%	0.33%
Payout Ratio	68.07%	68.07%	52.13%	31.44%	34.88%	40.32%
Buyback Yield / Dilution	-0.00%	-0.00%	0.51%	0.68%	0.60%	-0.27%
Total Shareholder Return	4.82%	0.53%	1.04%	1.15%	1.03%	0.06%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.